213 related articles for article (PubMed ID: 19530513)
21. CD133 and CD133-regulated nucleophosmin linked to 5-fluorouracil susceptibility in human colon cancer cell line SW620.
Kim KH; Yoo BC; Kim WK; Hong JP; Kim K; Song EY; Lee JY; Cho JY; Ku JL
Electrophoresis; 2014 Feb; 35(4):522-32. PubMed ID: 24339132
[TBL] [Abstract][Full Text] [Related]
22. CD133 as a marker for cancer stem cells: progresses and concerns.
Wu Y; Wu PY
Stem Cells Dev; 2009 Oct; 18(8):1127-34. PubMed ID: 19409053
[TBL] [Abstract][Full Text] [Related]
23. Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma.
Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Mori T; Yoshii H; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
Nucl Med Biol; 2011 Feb; 38(2):151-7. PubMed ID: 21315269
[TBL] [Abstract][Full Text] [Related]
24. Biology and clinical implications of CD133(+) liver cancer stem cells.
Ma S
Exp Cell Res; 2013 Jan; 319(2):126-32. PubMed ID: 22999864
[TBL] [Abstract][Full Text] [Related]
25. Cytometric profiling of CD133+ cells in human colon
carcinoma cell lines identifies a common core phenotype
and cell type-specific mosaics.
Gemei M; Di Noto R; Mirabelli P; Del Vecchio L
Int J Biol Markers; 2013 Sep; 28(3):267-73. PubMed ID: 23709346
[TBL] [Abstract][Full Text] [Related]
26. STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH⁺/CD133⁺ stem cell-like human colon cancer cells.
Lin L; Fuchs J; Li C; Olson V; Bekaii-Saab T; Lin J
Biochem Biophys Res Commun; 2011 Dec; 416(3-4):246-51. PubMed ID: 22074823
[TBL] [Abstract][Full Text] [Related]
27. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.
Pallini R; Ricci-Vitiani L; Montano N; Mollinari C; Biffoni M; Cenci T; Pierconti F; Martini M; De Maria R; Larocca LM
Cancer; 2011 Jan; 117(1):162-74. PubMed ID: 20806346
[TBL] [Abstract][Full Text] [Related]
28. How powerful is CD133 as a cancer stem cell marker in brain tumors?
Cheng JX; Liu BL; Zhang X
Cancer Treat Rev; 2009 Aug; 35(5):403-8. PubMed ID: 19369008
[TBL] [Abstract][Full Text] [Related]
29. CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo.
Gemei M; Mirabelli P; Di Noto R; Corbo C; Iaccarino A; Zamboli A; Troncone G; Galizia G; Lieto E; Del Vecchio L; Salvatore F
Cancer; 2013 Feb; 119(4):729-38. PubMed ID: 23027178
[TBL] [Abstract][Full Text] [Related]
30. Protein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of SRp20 that is potentially involved in tumorigenicity.
Corbo C; Orrù S; Gemei M; Noto RD; Mirabelli P; Imperlini E; Ruoppolo M; Vecchio LD; Salvatore F
Proteomics; 2012 Jun; 12(12):2045-59. PubMed ID: 22623141
[TBL] [Abstract][Full Text] [Related]
31. Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus.
Bach P; Abel T; Hoffmann C; Gal Z; Braun G; Voelker I; Ball CR; Johnston IC; Lauer UM; Herold-Mende C; Mühlebach MD; Glimm H; Buchholz CJ
Cancer Res; 2013 Jan; 73(2):865-74. PubMed ID: 23293278
[TBL] [Abstract][Full Text] [Related]
32. Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells.
Rentala S; Mangamoori LN
J Stem Cells; 2010; 5(2):75-81. PubMed ID: 22049617
[TBL] [Abstract][Full Text] [Related]
33. Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells: implications for its detection.
Sgambato A; Puglisi MA; Errico F; Rafanelli F; Boninsegna A; Rettino A; Genovese G; Coco C; Gasbarrini A; Cittadini A
J Cell Physiol; 2010 Jul; 224(1):234-41. PubMed ID: 20333645
[TBL] [Abstract][Full Text] [Related]
34. Expression of CD133-1 and CD133-2 in ovarian cancer.
Ferrandina G; Bonanno G; Pierelli L; Perillo A; Procoli A; Mariotti A; Corallo M; Martinelli E; Rutella S; Paglia A; Zannoni G; Mancuso S; Scambia G
Int J Gynecol Cancer; 2008; 18(3):506-14. PubMed ID: 17868344
[TBL] [Abstract][Full Text] [Related]
35. Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice.
Rountree CB; Ding W; He L; Stiles B
Stem Cells; 2009 Feb; 27(2):290-9. PubMed ID: 19008348
[TBL] [Abstract][Full Text] [Related]
36. Limits of CD133 as a marker of glioma self-renewing cells.
Clément V; Dutoit V; Marino D; Dietrich PY; Radovanovic I
Int J Cancer; 2009 Jul; 125(1):244-8. PubMed ID: 19350631
[TBL] [Abstract][Full Text] [Related]
37. CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116.
Dittfeld C; Dietrich A; Peickert S; Hering S; Baumann M; Grade M; Ried T; Kunz-Schughart LA
Radiother Oncol; 2009 Sep; 92(3):353-61. PubMed ID: 19699546
[TBL] [Abstract][Full Text] [Related]
38. [Investigation of CD133 as putative marker of tumor-initiating cell in laryngeal carcinoma].
Wei XD; Zhou L; Cheng L; Tian J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 42(9):692-6. PubMed ID: 18051573
[TBL] [Abstract][Full Text] [Related]
39. DDX4 (DEAD box polypeptide 4) colocalizes with cancer stem cell marker CD133 in ovarian cancers.
Kim KH; Kang YJ; Jo JO; Ock MS; Moon SH; Suh DS; Yoon MS; Park ES; Jeong N; Eo WK; Kim HY; Cha HJ
Biochem Biophys Res Commun; 2014 May; 447(2):315-22. PubMed ID: 24727449
[TBL] [Abstract][Full Text] [Related]
40. Response to stress in early tumor colonization modulates switching of CD133-positive and CD133-negative subpopulations in a human metastatic colon cancer cell line, SW620.
Hsu CS; Tung CY; Yang CY; Lin CH
PLoS One; 2013; 8(4):e61133. PubMed ID: 23577199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
